Qiagen N.V. (LON:0RLT)

Market Cap	7.81B
Revenue (ttm)	1.49B
Net Income (ttm)	272.53M
Shares Out	n/a
EPS (ttm)	1.24
PE Ratio	28.67
Forward PE	19.80
Dividend	1.20 (2.93%)
Ex-Dividend Date	Jul 2, 2025

Volume	148,248
Average Volume	60,753
Open	41.05
Previous Close	41.21
Day's Range	40.83 - 41.49
52-Week Range	34.39 - 51.23
Beta	0.67
RSI	59.29
Earnings Date	Oct 26, 2025

About Qiagen

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally. The company offers primary sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, such as kits and components for purification of nucleic acids; and...

• Industry: Laboratory Analytical Instruments
• Founded: 1984
• Employees: 5,396
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RLT

Financial Performance

In 2024, Qiagen's revenue was $1.98 billion, an increase of 0.66% compared to the previous year's $1.97 billion. Earnings were $83.59 million, a decrease of -75.51%.

Financial numbers in USD